Cellular pharmacology studies of anticancer agents: recommendations from the EORTC-PAMM group

Paola Perego, Georg Hempel, Stig Linder, Tracey D Bradshaw, Annette K Larsen, Godefridus J Peters, Roger M Phillips, EORTC PAMM Group

Research output: Contribution to journalReview articleAcademicpeer-review

Abstract

An increasing number of manuscripts focus on the in vitro evaluation of established and novel anti-tumor agents in experimental models. Whilst the design of such in vitro assays is inherently flexible, some of these studies lack the minimum information necessary to critically evaluate their relevance or have been carried out under unsuitable conditions. The use of appropriate and robust methods and experimental design has important implications for generating results that are reliable, relevant, and reproducible. The Pharmacology and Molecular Mechanisms (PAMM) group of the European Organization for Research and Treatment of Cancer (EORTC) is the largest group of academic scientists working on drug development and bundle decades of expertise in this field. This position paper addresses all researchers with an interest in the preclinical and cellular pharmacology of anti-tumor agents and aims at generating basic recommendations for the correct use of compounds to be tested for anti-tumor activity using a range of preclinical cellular models of cancer.

Original languageEnglish
Pages (from-to)427-441
Number of pages15
JournalCancer Chemotherapy and Pharmacology
Volume81
Issue number3
DOIs
Publication statusPublished - Mar 2018

Cite this

Perego, Paola ; Hempel, Georg ; Linder, Stig ; Bradshaw, Tracey D ; Larsen, Annette K ; Peters, Godefridus J ; Phillips, Roger M ; EORTC PAMM Group. / Cellular pharmacology studies of anticancer agents : recommendations from the EORTC-PAMM group. In: Cancer Chemotherapy and Pharmacology. 2018 ; Vol. 81, No. 3. pp. 427-441.
@article{ea5248300fc940b886d758a7b3c09a43,
title = "Cellular pharmacology studies of anticancer agents: recommendations from the EORTC-PAMM group",
abstract = "An increasing number of manuscripts focus on the in vitro evaluation of established and novel anti-tumor agents in experimental models. Whilst the design of such in vitro assays is inherently flexible, some of these studies lack the minimum information necessary to critically evaluate their relevance or have been carried out under unsuitable conditions. The use of appropriate and robust methods and experimental design has important implications for generating results that are reliable, relevant, and reproducible. The Pharmacology and Molecular Mechanisms (PAMM) group of the European Organization for Research and Treatment of Cancer (EORTC) is the largest group of academic scientists working on drug development and bundle decades of expertise in this field. This position paper addresses all researchers with an interest in the preclinical and cellular pharmacology of anti-tumor agents and aims at generating basic recommendations for the correct use of compounds to be tested for anti-tumor activity using a range of preclinical cellular models of cancer.",
keywords = "Journal Article, Review",
author = "Paola Perego and Georg Hempel and Stig Linder and Bradshaw, {Tracey D} and Larsen, {Annette K} and Peters, {Godefridus J} and Phillips, {Roger M} and {EORTC PAMM Group}",
year = "2018",
month = "3",
doi = "10.1007/s00280-017-3502-7",
language = "English",
volume = "81",
pages = "427--441",
journal = "Cancer Chemotherapy and Pharmacology",
issn = "0344-5704",
publisher = "Springer Verlag",
number = "3",

}

Perego, P, Hempel, G, Linder, S, Bradshaw, TD, Larsen, AK, Peters, GJ, Phillips, RM & EORTC PAMM Group 2018, 'Cellular pharmacology studies of anticancer agents: recommendations from the EORTC-PAMM group' Cancer Chemotherapy and Pharmacology, vol. 81, no. 3, pp. 427-441. https://doi.org/10.1007/s00280-017-3502-7

Cellular pharmacology studies of anticancer agents : recommendations from the EORTC-PAMM group. / Perego, Paola; Hempel, Georg; Linder, Stig; Bradshaw, Tracey D; Larsen, Annette K; Peters, Godefridus J; Phillips, Roger M; EORTC PAMM Group.

In: Cancer Chemotherapy and Pharmacology, Vol. 81, No. 3, 03.2018, p. 427-441.

Research output: Contribution to journalReview articleAcademicpeer-review

TY - JOUR

T1 - Cellular pharmacology studies of anticancer agents

T2 - recommendations from the EORTC-PAMM group

AU - Perego, Paola

AU - Hempel, Georg

AU - Linder, Stig

AU - Bradshaw, Tracey D

AU - Larsen, Annette K

AU - Peters, Godefridus J

AU - Phillips, Roger M

AU - EORTC PAMM Group

PY - 2018/3

Y1 - 2018/3

N2 - An increasing number of manuscripts focus on the in vitro evaluation of established and novel anti-tumor agents in experimental models. Whilst the design of such in vitro assays is inherently flexible, some of these studies lack the minimum information necessary to critically evaluate their relevance or have been carried out under unsuitable conditions. The use of appropriate and robust methods and experimental design has important implications for generating results that are reliable, relevant, and reproducible. The Pharmacology and Molecular Mechanisms (PAMM) group of the European Organization for Research and Treatment of Cancer (EORTC) is the largest group of academic scientists working on drug development and bundle decades of expertise in this field. This position paper addresses all researchers with an interest in the preclinical and cellular pharmacology of anti-tumor agents and aims at generating basic recommendations for the correct use of compounds to be tested for anti-tumor activity using a range of preclinical cellular models of cancer.

AB - An increasing number of manuscripts focus on the in vitro evaluation of established and novel anti-tumor agents in experimental models. Whilst the design of such in vitro assays is inherently flexible, some of these studies lack the minimum information necessary to critically evaluate their relevance or have been carried out under unsuitable conditions. The use of appropriate and robust methods and experimental design has important implications for generating results that are reliable, relevant, and reproducible. The Pharmacology and Molecular Mechanisms (PAMM) group of the European Organization for Research and Treatment of Cancer (EORTC) is the largest group of academic scientists working on drug development and bundle decades of expertise in this field. This position paper addresses all researchers with an interest in the preclinical and cellular pharmacology of anti-tumor agents and aims at generating basic recommendations for the correct use of compounds to be tested for anti-tumor activity using a range of preclinical cellular models of cancer.

KW - Journal Article

KW - Review

U2 - 10.1007/s00280-017-3502-7

DO - 10.1007/s00280-017-3502-7

M3 - Review article

VL - 81

SP - 427

EP - 441

JO - Cancer Chemotherapy and Pharmacology

JF - Cancer Chemotherapy and Pharmacology

SN - 0344-5704

IS - 3

ER -